Buenos Aires Province issues health alert over growing use and promotion of nicotine pouches

Jan.13
Buenos Aires Province issues health alert over growing use and promotion of nicotine pouches
The Ministry of Health of the Province of Buenos Aires issued a health alert to the public and health teams over increased circulation, promotion and consumption of nicotine pouches. It said the disposable oral products dissolve in the mouth without combustion or vapor and are marketed as tobacco-free, but contain nicotine and have a high addictive potential.

Key points

 

• Buenos Aires Province health ministry issued an alert on rising nicotine pouch circulation, promotion and use

• Pouches are disposable oral products placed between the lip and gum, releasing nicotine via oral mucosa for about 30 minutes

• The ministry says they are marketed as “smoke- and vapor-free” and “tobacco-free,” but contain addictive nicotine

• It cites warnings that high-concentration pouches may produce blood nicotine levels exceeding cigarettes, with heart and nervous-system harms

• The ministry says there is no health authorization for commercialization and no specific nicotine-pouch regulation

 


 

2Firsts, January 13, 2026 – According to the Ministry of Health of the Province of Buenos Aires, the ministry issued a health alert to the public and health teams regarding growing circulation, promotion and consumption of nicotine pouches.

 

The ministry described nicotine pouches as disposable products that do not require combustion or vapor and dissolve in the mouth without the need to spit. It said they are sold as tobacco-free but contain nicotine and have a high addictive potential. Citing risks and the absence of health authorization for commercialization, the ministry said it seeks to limit consumption of this product strategy attributed to the tobacco industry, describing it as particularly dangerous for children, adolescents and young people by increasing early nicotine exposure and facilitating initiation among those more vulnerable to addiction.

 

The ministry said pouches are small oral-use bags placed between the lip and gum and contain a powder with flavorings that releases nicotine through absorption via the oral mucosa for about 30 minutes. It said the products began being marketed in Argentina in 2025 and have been promoted with the slogan “Sin humo ni vapor, cuando quieras, donde quieras,” alongside the warning: “Este producto no es libre de riesgos y contiene nicotina, que es adictiva. Venta exclusiva para adultos.”

 

The ministry cited specialist warnings that in high-concentration products, blood nicotine levels can even exceed those reached with conventional cigarettes, increasing addictive potential and harm to the heart and nervous system.

 

On regulation, it said Argentina does not yet have a specific rule expressly regulating this product, and that there are no current health permits or authorizations for commercialization; it added they could be treated similarly to existing restrictions on tobacco-derived products. It referenced Buenos Aires Province Law No. 13.894 as a general framework to protect health from the promotion and consumption of tobacco products and/or derivatives, with special attention to children and adolescents.

 

2Firsts has noticed that the BAT in Argentina claims to have launched VELO nicotine pouches as a tobacco-free, non-combustible alternative for adults. At the same time, social media and media reports indicate that Philip Morris International (PMI) ZYN has also been reported to be available in the Argentine market.

 

Image source: Buenos Aires Province Health Department

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Interpreting FDA’s on! PLUS Authorization: What the Agency’s Press Release Reveals About Its Nicotine Pouch Review Model
Interpreting FDA’s on! PLUS Authorization: What the Agency’s Press Release Reveals About Its Nicotine Pouch Review Model
The U.S. Food and Drug Administration has confirmed that six on! PLUS nicotine pouch products have received Marketing Granted Orders (MGO) through the PMTA pathway. The authorizations were completed under the agency’s nicotine pouch review pilot program in “record time,” with the FDA citing lower levels of harmful constituents while stressing that the decision applies only to the specified products and does not mean they are safe or FDA approved.
Regulations
Dec.20
After Export Tax Rebates Go to Zero: How China’s E-Cigarette Supply Chain Is Being Reshaped, According to 2Firsts Research
After Export Tax Rebates Go to Zero: How China’s E-Cigarette Supply Chain Is Being Reshaped, According to 2Firsts Research
China’s e-cigarette industry is adjusting to a major policy shift. From April 1, 2026, China will scrap the 13% export VAT rebate on e-cigarette products, a move affecting manufacturers centered in Shenzhen. Industry participants told 2Firsts the change is forcing a reassessment of pricing and capacity, with competition shifting toward cash flow resilience, regulatory compliance, and multi-location strategies.
Industry Insight
Jan.16
Brazil’s federal prosecutors sue for strict e-cigarette rules, urging regulation over a “paper ban”
Brazil’s federal prosecutors sue for strict e-cigarette rules, urging regulation over a “paper ban”
Brazil’s Federal Public Prosecutor’s Office (MPF) has filed a public civil action seeking to compel the federal government and Anvisa to establish a strict, enforceable regulatory framework for electronic smoking devices, replacing the current blanket ban. The lawsuit calls for mandatory product registration, nicotine caps, bans on youth-targeted advertising, and clear health warnings on packaging, and demands a national consumption report and an implementation timetable within 90 days.
Jan.30 by 2FIRSTS.ai
China’s E-Cigarette Exports Fall Slightly to USD 10.6 Billion in 2025, U.S. Market Further Consolidates Lead
China’s E-Cigarette Exports Fall Slightly to USD 10.6 Billion in 2025, U.S. Market Further Consolidates Lead
China’s e-cigarette exports totaled approximately USD 10.60 billion in 2025, down 3.3% year-on-year from USD 10.96 billion in 2024, according to annual trade data released by the General Administration of Customs of China. Despite the mild decline, exports remained firmly above the USD 10 billion mark, with a clear rebound in the fourth quarter.
Jan.20 by 2FIRSTS.ai
TGA Sets 2026–2027 Compliance Principles, Flags Vaping Goods as a 2026 Priority
TGA Sets 2026–2027 Compliance Principles, Flags Vaping Goods as a 2026 Priority
The Therapeutic Goods Administration (TGA) has released its Compliance Principles for 2026 and 2027.Among 12 therapeutic goods categories identified for priority compliance and enforcement activity, TGA includes vaping goods, and it plans a further review of these priorities in March 2026.
Jan.23 by 2FIRSTS.ai
BREAKING: China Brings Nicotine Pouches Under Tobacco Monopoly Regulation, Signaling Major Shift for Oral Products
BREAKING: China Brings Nicotine Pouches Under Tobacco Monopoly Regulation, Signaling Major Shift for Oral Products
China has for the first time issued clear regulatory rules for nicotine pouches and other oral nicotine products, formally classifying them under the tobacco monopoly alongside cigarettes and tobacco, ending a long-standing legal grey zone and laying the regulatory groundwork for their potential domestic launch.
Jan.09 by Alan Zhao | 2Firsts Perspectives